Concepts (68)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cinnamates | 5 | 2018 | 15 | 1.770 |
Why?
|
| Colonic Neoplasms | 6 | 2020 | 248 | 1.600 |
Why?
|
| Anticarcinogenic Agents | 3 | 2018 | 57 | 1.160 |
Why?
|
| 1,2-Dimethylhydrazine | 3 | 2018 | 5 | 1.090 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2022 | 119 | 0.740 |
Why?
|
| Actins | 1 | 2022 | 346 | 0.670 |
Why?
|
| Carcinogenesis | 2 | 2018 | 333 | 0.510 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2018 | 293 | 0.500 |
Why?
|
| Antineoplastic Agents | 3 | 2020 | 1691 | 0.400 |
Why?
|
| Colon | 1 | 2014 | 351 | 0.370 |
Why?
|
| Nanotubes, Carbon | 2 | 2022 | 19 | 0.370 |
Why?
|
| Mitochondria | 1 | 2015 | 680 | 0.350 |
Why?
|
| Bacteria | 1 | 2014 | 484 | 0.340 |
Why?
|
| Adenocarcinoma | 1 | 2015 | 1026 | 0.290 |
Why?
|
| Liver | 1 | 2014 | 1748 | 0.270 |
Why?
|
| Rats, Wistar | 3 | 2018 | 381 | 0.260 |
Why?
|
| Depsides | 2 | 2016 | 2 | 0.230 |
Why?
|
| Mesothelioma | 2 | 2022 | 88 | 0.220 |
Why?
|
| Carcinogens | 3 | 2018 | 152 | 0.200 |
Why?
|
| Nuclear Matrix | 1 | 2022 | 27 | 0.200 |
Why?
|
| Actin Cytoskeleton | 1 | 2022 | 43 | 0.190 |
Why?
|
| Apoptosis | 3 | 2018 | 1806 | 0.190 |
Why?
|
| Rats | 5 | 2022 | 3727 | 0.190 |
Why?
|
| Embryonic Development | 1 | 2022 | 214 | 0.170 |
Why?
|
| Lactoferrin | 1 | 2020 | 78 | 0.170 |
Why?
|
| Cell Nucleus | 1 | 2022 | 676 | 0.160 |
Why?
|
| Air Pollutants | 1 | 2020 | 102 | 0.160 |
Why?
|
| Disease Models, Animal | 3 | 2020 | 4395 | 0.150 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2018 | 151 | 0.140 |
Why?
|
| Crohn Disease | 1 | 2020 | 280 | 0.140 |
Why?
|
| Phytochemicals | 1 | 2015 | 8 | 0.120 |
Why?
|
| HT29 Cells | 1 | 2015 | 44 | 0.120 |
Why?
|
| HCT116 Cells | 1 | 2015 | 55 | 0.120 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2015 | 51 | 0.120 |
Why?
|
| Lung Neoplasms | 2 | 2022 | 1659 | 0.120 |
Why?
|
| Cell Differentiation | 1 | 2022 | 1898 | 0.120 |
Why?
|
| Biotransformation | 1 | 2014 | 50 | 0.110 |
Why?
|
| Cytoprotection | 1 | 2014 | 38 | 0.110 |
Why?
|
| Feces | 2 | 2016 | 727 | 0.110 |
Why?
|
| Cell Survival | 1 | 2015 | 813 | 0.100 |
Why?
|
| Animals | 7 | 2022 | 34232 | 0.100 |
Why?
|
| Inflammation | 1 | 2020 | 1446 | 0.100 |
Why?
|
| Oxidative Stress | 2 | 2015 | 837 | 0.100 |
Why?
|
| Reactive Oxygen Species | 1 | 2015 | 499 | 0.100 |
Why?
|
| Inhalation Exposure | 2 | 2022 | 36 | 0.090 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2014 | 1697 | 0.090 |
Why?
|
| Cell Line, Tumor | 1 | 2015 | 3348 | 0.070 |
Why?
|
| Cell Proliferation | 1 | 2015 | 2311 | 0.070 |
Why?
|
| Male | 4 | 2020 | 61525 | 0.050 |
Why?
|
| Lung | 2 | 2022 | 1496 | 0.050 |
Why?
|
| Pleura | 1 | 2022 | 25 | 0.050 |
Why?
|
| Asbestos, Crocidolite | 1 | 2020 | 1 | 0.040 |
Why?
|
| Carcinogenicity Tests | 1 | 2020 | 20 | 0.040 |
Why?
|
| Cattle | 1 | 2020 | 568 | 0.040 |
Why?
|
| Trachea | 1 | 2020 | 203 | 0.040 |
Why?
|
| Administration, Oral | 1 | 2020 | 684 | 0.040 |
Why?
|
| Xenobiotics | 1 | 2016 | 26 | 0.030 |
Why?
|
| Lipid Peroxidation | 1 | 2016 | 97 | 0.030 |
Why?
|
| Body Weight | 1 | 2016 | 989 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2016 | 723 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2020 | 4404 | 0.020 |
Why?
|
| Intestinal Mucosa | 1 | 2016 | 778 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2016 | 2820 | 0.020 |
Why?
|
| Antioxidants | 1 | 2012 | 369 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2016 | 1893 | 0.020 |
Why?
|
| Dietary Supplements | 1 | 2012 | 472 | 0.020 |
Why?
|
| Humans | 1 | 2015 | 125189 | 0.010 |
Why?
|
| Mice | 1 | 2020 | 17631 | 0.010 |
Why?
|